Ophthalmic Devices - Niger | Statista Market Forecast

The projected revenue in the Ophthalmic Devices market market in Niger is set to reach US$6.11m in 2024.
Moving forward, the revenue is expected to display an annual growth rate (CAGR 2024-2029) of 9.62%, leading to a market volume of US$9.68m by 2029.
When compared globally, the United States is anticipated to generate the highest revenue, amounting to US$14.00bn in 2024.
Niger is witnessing a surge in demand for ophthalmic devices due to an increasing prevalence of eye diseases and improving healthcare infrastructure.

Definition:
Ophthalmic devices refer to medical devices used for diagnosis of eye diseases, related surgeries, and vision correction.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Essilor International, Johnson & Johnson, Bausch Health Companies. Further information on the key players can be found in the Market Shares boxes.

Ophthalmology diagnostic & surgical devices
Vision care

Ophthalmology pharmaceuticals
Ophthalmology supplements

The Ophthalmic Devices market in Niger is developing rapidly due to increasing customer preferences for advanced eye care solutions and the growing prevalence of eye diseases in the country. Customer preferences in the Ophthalmic Devices market in Niger are shifting towards more advanced and technologically advanced products. Customers are seeking innovative devices that offer better accuracy, precision, and comfort in diagnosing and treating eye conditions. This preference is driven by the increasing awareness about the benefits of early detection and treatment of eye diseases, as well as the desire for improved quality of life. Additionally, customers are also looking for devices that are easy to use and maintain, as well as those that offer cost-effective solutions. The Ophthalmic Devices market in Niger is experiencing several trends that are shaping its growth. One of the key trends in the market is the increasing adoption of digital imaging and diagnostic devices. These devices provide high-resolution images of the eye, allowing for more accurate diagnosis and treatment planning. Another trend is the growing demand for refractive surgery devices, such as LASIK machines. This is driven by the increasing number of people seeking vision correction procedures to reduce their dependence on glasses or contact lenses. Additionally, there is a rising demand for ophthalmic surgical instruments, as more complex and specialized eye surgeries are being performed in Niger. Local special circumstances in Niger also contribute to the development of the Ophthalmic Devices market. The country has a high prevalence of eye diseases, including cataracts, glaucoma, and refractive errors. This creates a significant demand for ophthalmic devices that can diagnose and treat these conditions effectively. Moreover, Niger has a growing elderly population, which is more prone to age-related eye diseases. This further drives the demand for ophthalmic devices, as older individuals require more frequent eye examinations and treatments. Underlying macroeconomic factors also play a role in the development of the Ophthalmic Devices market in Niger. The country has been experiencing economic growth in recent years, leading to an increase in disposable income among the population. This allows more people to afford eye care services and invest in ophthalmic devices. Additionally, the government of Niger has been focusing on improving healthcare infrastructure and services, including eye care. This has resulted in increased access to eye care facilities and a higher demand for ophthalmic devices. In conclusion, the Ophthalmic Devices market in Niger is experiencing rapid development due to increasing customer preferences for advanced eye care solutions, the growing prevalence of eye diseases, and the favorable macroeconomic factors in the country. The market is witnessing a shift towards more technologically advanced devices, such as digital imaging and refractive surgery devices. Local special circumstances, such as the high prevalence of eye diseases and the growing elderly population, further contribute to the growth of the market. Overall, the Ophthalmic Devices market in Niger is expected to continue expanding in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.